Luminera Hydryalix Gentle Lidocaine (2×1.25ml)

Description

MEDICAL STRICT USE. Medical device. Injection of hyaluronic acid. Use reserved for dermatologists and aesthetic doctors because requiring a medical procedure.

PROPERTIES

HYDRYALIX GENTLE LIDO LUMINERA: a high-end product.
HYDRYALIX GENTLE LIDO is a CE certified injectable filling substance based on cross-linked, sterile and transparent hyaluronic acid (HA). Homogeneous biodegradable and durable gel.
HYDRYALIX contains hyaluronic acid of non-animal origin, cross-linked with BDDE. The longevity of hyaluronic acid molecules is enhanced by the BDDE crosslinking procedure which creates a new 3D network.
Produced in a factory conforming to ISO9001 & ISO13485 standards.

COMPOSITION

• The concentration of hyaluronic acid is 20 mg / ml.
• 0.3% Lidocaine.
• Texture gel: 100-300 µm.
• The residual BDDE in the final product is less than 2 ppm.

NDICATIONS

HYDRYALIX GENTLE LIDO is used for superficial wrinkles, fine to moderate wrinkles, and slightly damaged skin. It can be used to fill wrinkles, fine lines and folds around the mouth. Excellent for rejuvenating the skin. The gel being monophasic, it is smooth, homogeneous and easy to inject.

INJECTION

Recommended needles are thin walled 27 or 30G. The product comes in 2 pre-filled syringes of 1.25 ml. It must be injected into the superficial and middle dermis.
Mixed MoBi TECHNOLOGY. The cutting-edge technology used by Luminera to produce HYDRYALIX, our range of products based on cross-linked hyaluronic acid, combines the advantages associated with monophasic crosslinking and the properties of biphasic gel. The homogeneously cross-linked monophasic gel is both smooth and uniform. It reduces unwanted effects such as swelling and Tyndall effect, and its cross-linking process uses less BDDE. The monophasic gel is 100% crosslinked.
The biphasic gel combines two phases: a phase of highly crosslinked hyaluronic acid particles, and a phase of uncrosslinked hyaluronic acid whose particles are in suspension. This uncrosslinked phase is necessary for the injection. Our mixed MoBiTM technology makes it possible to obtain a monophasic gel, completely homogeneous, smooth and easy to inject.